SOX30 and prostate carcinoma: Moreover, our data show that knockdown of SOX30 partially reverses the miR-653-5p downregulation-induced tumor-suppressive effect in prostate cancer cells, indicating that SOX30 is a functional target of miR-653-5p in prostate cancer.